martes, 20 de agosto de 2019

Northwest Bio needed cash, so it turned to a predatory lender: its own CEO

Northwest Bio needed cash, so it turned to a predatory lender: its own CEO

Cancer Briefing

This troubled biotech needed cash, so it turned to a predatory lender: its own CEO

By ADAM FEUERSTEIN


The company raised $4 million in the second quarter, then immediately turned around and wrote a check for $4.7 million to its chief executive Linda Powers.

No hay comentarios: